179 related articles for article (PubMed ID: 33412151)
1. Role of stealth lipids in nanomedicine-based drug carriers.
Rastogi M; Saha RN; Alexander A; Singhvi G; Puri A; Dubey SK
Chem Phys Lipids; 2021 Mar; 235():105036. PubMed ID: 33412151
[TBL] [Abstract][Full Text] [Related]
2. To PEGylate or not to PEGylate: Immunological properties of nanomedicine's most popular component, polyethylene glycol and its alternatives.
Shi D; Beasock D; Fessler A; Szebeni J; Ljubimova JY; Afonin KA; Dobrovolskaia MA
Adv Drug Deliv Rev; 2022 Jan; 180():114079. PubMed ID: 34902516
[TBL] [Abstract][Full Text] [Related]
3. Application of polyglycerol coating to plasmid DNA lipoplex for the evasion of the accelerated blood clearance phenomenon in nucleic acid delivery.
Abu Lila AS; Uehara Y; Ishida T; Kiwada H
J Pharm Sci; 2014 Feb; 103(2):557-66. PubMed ID: 24347396
[TBL] [Abstract][Full Text] [Related]
4. Bioinspired "Active" Stealth Magneto-Nanomicelles for Theranostics Combining Efficient MRI and Enhanced Drug Delivery.
Zhang KL; Zhou J; Zhou H; Wu Y; Liu R; Wang LL; Lin WW; Huang G; Yang HH
ACS Appl Mater Interfaces; 2017 Sep; 9(36):30502-30509. PubMed ID: 28812358
[TBL] [Abstract][Full Text] [Related]
5. Curcumin-guided nanotherapy: a lipid-based nanomedicine for targeted drug delivery in breast cancer therapy.
Lin M; Teng L; Wang Y; Zhang J; Sun X
Drug Deliv; 2016 May; 23(4):1420-5. PubMed ID: 26203688
[TBL] [Abstract][Full Text] [Related]
6. [Elucidation of accelerated blood clearance phenomenon caused by repeat injection of PEGylated nanocarriers].
Koide H; Asai T; Hatanaka K; Shimizu K; Yokoyama M; Ishida T; Kiwada H; Oku N
Yakugaku Zasshi; 2009 Dec; 129(12):1445-51. PubMed ID: 19952519
[TBL] [Abstract][Full Text] [Related]
7. Surface functionalized cationic lipid-DNA complexes for gene delivery: PEGylated lamellar complexes exhibit distinct DNA-DNA interaction regimes.
Martin-Herranz A; Ahmad A; Evans HM; Ewert K; Schulze U; Safinya CR
Biophys J; 2004 Feb; 86(2):1160-8. PubMed ID: 14747350
[TBL] [Abstract][Full Text] [Related]
8. Advanced drug delivery to the lymphatic system: lipid-based nanoformulations.
Ali Khan A; Mudassir J; Mohtar N; Darwis Y
Int J Nanomedicine; 2013; 8():2733-44. PubMed ID: 23926431
[TBL] [Abstract][Full Text] [Related]
9. Accelerated Blood Clearance of Nanoemulsions Modified with PEG-Cholesterol and PEG-Phospholipid Derivatives in Rats: The Effect of PEG-Lipid Linkages and PEG Molecular Weights.
Liu M; Chu Y; Liu H; Su Y; Zhang Q; Jiao J; Liu M; Ding J; Liu M; Hu Y; Dai Y; Zhang R; Liu X; Deng Y; Song Y
Mol Pharm; 2020 Apr; 17(4):1059-1070. PubMed ID: 31860321
[TBL] [Abstract][Full Text] [Related]
10. Brush Conformation of Polyethylene Glycol Determines the Stealth Effect of Nanocarriers in the Low Protein Adsorption Regime.
Li M; Jiang S; Simon J; Paßlick D; Frey ML; Wagner M; Mailänder V; Crespy D; Landfester K
Nano Lett; 2021 Feb; 21(4):1591-1598. PubMed ID: 33560851
[TBL] [Abstract][Full Text] [Related]
11. DePEGylation strategies to increase cancer nanomedicine efficacy.
Kong L; Campbell F; Kros A
Nanoscale Horiz; 2019 Mar; 4(2):378-387. PubMed ID: 32254090
[TBL] [Abstract][Full Text] [Related]
12. Comparison of two kinds of nanomedicine for targeted gene therapy: premodified or postmodified gene delivery systems.
Jiang Z; Sun C; Yin Z; Zhou F; Ge L; Liu X; Kong F
Int J Nanomedicine; 2012; 7():2019-31. PubMed ID: 22619539
[TBL] [Abstract][Full Text] [Related]
13. Rational Design of Cancer Nanomedicine for Simultaneous Stealth Surface and Enhanced Cellular Uptake.
Jin Q; Deng Y; Chen X; Ji J
ACS Nano; 2019 Feb; 13(2):954-977. PubMed ID: 30681834
[TBL] [Abstract][Full Text] [Related]
14. Evasion of the accelerated blood clearance phenomenon by branched PEG lipid derivative coating of nanoemulsions.
Liu M; Zhao D; Yan N; Li J; Zhang H; Liu M; Tang X; Liu X; Deng Y; Song Y; Zhao X
Int J Pharm; 2022 Jan; 612():121365. PubMed ID: 34896215
[TBL] [Abstract][Full Text] [Related]
15. 'Stealth' lipid-based formulations: poly(ethylene glycol)-mediated digestion inhibition improves oral bioavailability of a model poorly water soluble drug.
Feeney OM; Williams HD; Pouton CW; Porter CJ
J Control Release; 2014 Oct; 192():219-27. PubMed ID: 25058571
[TBL] [Abstract][Full Text] [Related]
16. Stealth Coating of Nanoparticles in Drug-Delivery Systems.
Fam SY; Chee CF; Yong CY; Ho KL; Mariatulqabtiah AR; Tan WS
Nanomaterials (Basel); 2020 Apr; 10(4):. PubMed ID: 32325941
[TBL] [Abstract][Full Text] [Related]
17. Stealth CD44-targeted hyaluronic acid supramolecular nanoassemblies for doxorubicin delivery: probing the effect of uncovalent pegylation degree on cellular uptake and blood long circulation.
Han X; Li Z; Sun J; Luo C; Li L; Liu Y; Du Y; Qiu S; Ai X; Wu C; Lian H; He Z
J Control Release; 2015 Jan; 197():29-40. PubMed ID: 25449802
[TBL] [Abstract][Full Text] [Related]
18. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
19. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
[TBL] [Abstract][Full Text] [Related]
20. Use of polyglycerol (PG), instead of polyethylene glycol (PEG), prevents induction of the accelerated blood clearance phenomenon against long-circulating liposomes upon repeated administration.
Abu Lila AS; Nawata K; Shimizu T; Ishida T; Kiwada H
Int J Pharm; 2013 Nov; 456(1):235-42. PubMed ID: 23928149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
